Mount Sinai and Rumi Scientific team up to advance autism drug discovery
E-Mail The Seaver Autism Center for Research and Treatment at the Icahn School of Medicine at Mount Sinai and Rumi Scientific announced today that they will team up to initiate a drug discovery pipeline for rare genetic disorders that carry a high risk of autism. The project will initially involve the development and use of a platform that mimics the development of brain tissues, at high speed, allowing researchers to gain insights into how cells respond to three known genes implicated in autism. "Over the past several years, more than 100 genes have been identified that confer very high ri...
Source: eurekalert.org